Literature DB >> 15861129

Myeloid leukemia factor 1 regulates p53 by suppressing COP1 via COP9 signalosome subunit 3.

Noriko Yoneda-Kato1, Kiichiro Tomoda, Mari Umehara, Yukinobu Arata, Jun-ya Kato.   

Abstract

Myeloid leukemia factor 1 (MLF1) was first identified as the leukemic fusion protein NPM-MLF1 generated by the t(3;5)(q25.1;q34) chromosomal translocation. Although MLF1 expresses normally in a variety of tissues including hematopoietic stem cells and the overexpression of MLF1 correlates with malignant transformation in human cancer, little is known about how MLF1 is involved in the regulation of cell growth. Here we show that MLF1 is a negative regulator of cell cycle progression functioning upstream of the tumor suppressor p53. MLF1 induces p53-dependent cell cycle arrest in murine embryonic fibroblasts. This action requires a novel binding partner, subunit 3 of the COP9 signalosome (CSN3). A reduction in the level of CSN3 protein with small interfering RNA abrogated MLF1-induced G1 arrest and impaired the activation of p53 by genotoxic stress. Furthermore, ectopic MLF1 expression and CSN3 knockdown inversely affect the endogenous level of COP1, a ubiquitin ligase for p53. Exogenous expression of COP1 overcomes MLF1-induced growth arrest. These results indicate that MLF1 is a critical regulator of p53 and suggest its involvement in leukemogenesis through a novel CSN3-COP1 pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15861129      PMCID: PMC1142586          DOI: 10.1038/sj.emboj.7600656

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  50 in total

Review 1.  Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer.

Authors:  M Hall; G Peters
Journal:  Adv Cancer Res       Date:  1996       Impact factor: 6.242

2.  Apoptosis induced by the myelodysplastic syndrome-associated NPM-MLF1 chimeric protein.

Authors:  N Yoneda-Kato; S Fukuhara; J Kato
Journal:  Oncogene       Date:  1999-06-24       Impact factor: 9.867

3.  Translocation of nucleolar phosphoprotein B23 (37 kDa/pI 5.1) induced by selective inhibitors of ribosome synthesis.

Authors:  B Y Yung; H Busch; P K Chan
Journal:  Biochim Biophys Acta       Date:  1985-12-18

Review 4.  Making sense of the COP9 signalosome. A regulatory protein complex conserved from Arabidopsis to human.

Authors:  N Wei; X W Deng
Journal:  Trends Genet       Date:  1999-03       Impact factor: 11.639

5.  Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1.

Authors:  K Tomoda; Y Kubota; J Kato
Journal:  Nature       Date:  1999-03-11       Impact factor: 49.962

6.  HLS7, a hemopoietic lineage switch gene homologous to the leukemia-inducing gene MLF1.

Authors:  J H Williams; L N Daly; E Ingley; J G Beaumont; P A Tilbrook; J P Lalonde; J P Stillitano; S P Klinken
Journal:  EMBO J       Date:  1999-10-15       Impact factor: 11.598

Review 7.  Oncogenic transcription factors in the human acute leukemias.

Authors:  A T Look
Journal:  Science       Date:  1997-11-07       Impact factor: 47.728

8.  A novel protein complex involved in signal transduction possessing similarities to 26S proteasome subunits.

Authors:  M Seeger; R Kraft; K Ferrell; D Bech-Otschir; R Dumdey; R Schade; C Gordon; M Naumann; W Dubiel
Journal:  FASEB J       Date:  1998-04       Impact factor: 5.191

9.  Evidence for FUS6 as a component of the nuclear-localized COP9 complex in Arabidopsis.

Authors:  J M Staub; N Wei; X W Deng
Journal:  Plant Cell       Date:  1996-11       Impact factor: 11.277

10.  The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus.

Authors:  J J Jacobs; K Kieboom; S Marino; R A DePinho; M van Lohuizen
Journal:  Nature       Date:  1999-01-14       Impact factor: 49.962

View more
  37 in total

Review 1.  The COP9 signalosome and vascular function: intriguing possibilities?

Authors:  Douglas S Martin; Xuejun Wang
Journal:  Am J Cardiovasc Dis       Date:  2015-03-20

2.  Myeloid leukemia factor 1 stabilizes tumor suppressor C/EBPα to prevent Trib1-driven acute myeloid leukemia.

Authors:  Ikuko Nakamae; Jun-Ya Kato; Takashi Yokoyama; Hidenori Ito; Noriko Yoneda-Kato
Journal:  Blood Adv       Date:  2017-09-01

3.  The COP9 signalosome interacts with and regulates interferon regulatory factor 5 protein stability.

Authors:  Justyna Korczeniewska; Betsy J Barnes
Journal:  Mol Cell Biol       Date:  2012-12-28       Impact factor: 4.272

4.  CSN1 inhibits c-Jun phosphorylation and down-regulates ectopic expression of JNK1.

Authors:  Tomohiko Tsuge; Suchithra Menon; Yingchun Tong; Ning Wei
Journal:  Protein Cell       Date:  2011-05-21       Impact factor: 14.870

5.  The Ubiquitin Ligase COP1 Promotes Glioma Cell Proliferation by Preferentially Downregulating Tumor Suppressor p53.

Authors:  Shenshan Zou; Yufu Zhu; Bin Wang; Fengyuan Qian; Xiang Zhang; Lei Wang; Chunling Fu; Hanmo Bao; Manyi Xie; Shangfeng Gao; Rutong Yu; Hengliang Shi
Journal:  Mol Neurobiol       Date:  2016-08-17       Impact factor: 5.590

6.  Estrogen induced breast cancer is the result in the disruption of the asymmetric cell division of the stem cell.

Authors:  Jose Russo; Kara Snider; Julia S Pereira; Irma H Russo
Journal:  Horm Mol Biol Clin Investig       Date:  2010-01-01

7.  Stable form of JAB1 enhances proliferation and maintenance of hematopoietic progenitors.

Authors:  Masaaki Mori; Noriko Yoneda-Kato; Akihiro Yoshida; Jun-ya Kato
Journal:  J Biol Chem       Date:  2008-07-30       Impact factor: 5.157

8.  Myeloid leukemia factor: a return ticket from human leukemia to fly hematopoiesis.

Authors:  Vanessa Gobert; Marc Haenlin; Lucas Waltzer
Journal:  Transcription       Date:  2012-09-01

9.  COP9 signalosome subunit Csn8 is involved in maintaining proper duration of the G1 phase.

Authors:  Cheng Liu; Li-Quan Guo; Suchithra Menon; Dan Jin; Elah Pick; Xuejun Wang; Xing Wang Deng; Ning Wei
Journal:  J Biol Chem       Date:  2013-05-20       Impact factor: 5.157

10.  Shuttling imbalance of MLF1 results in p53 instability and increases susceptibility to oncogenic transformation.

Authors:  Noriko Yoneda-Kato; Jun-Ya Kato
Journal:  Mol Cell Biol       Date:  2007-10-29       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.